User: Guest

MICROPLATE SYSTEMS

Global Market Trajectory & Analytics

MCP13317

VALIDATED EXECUTIVE ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

3936

Interactions with Platform & by Email *

INTERACTIONS

708

Unique # Participated *

PARTICIPANTS

118

Responses Validated *

VALIDATIONS

53

* Login to view program details and full enterprise executive list.


  •  DATE

    JULY 2020

  •  TABLES

    213

  •  PAGES

    473

  •  EDITION

    7

  •  PRICE

    USD $4950


GLOBAL EXECUTIVE SURVEY

Impact of Pandemic & Economic Slowdown

Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.

The global market for Microplate Systems is projected to reach US$950 million by 2025, driven by growing applications in life sciences/biotechnology research, pharmaceutical drug development, food safety testing and clinical diagnostics. Few of the macro factors priming these end-use markets for higher growth and technology adoption include rising healthcare burden shaped by growing population, aging population, spread of infectious diseases, rising prevalence of chronic lifestyle diseases, need for newer more effective drugs, and the resulting increase in healthcare R&D investments. Microplate systems are ubiquitous laboratory equipment comprising microplates, microplate readers, and microplate handling equipment. They play a key role in automation of bioassays encompassing biochemical and cell-based assays. High Throughput Screening (HTS) utilize microplates. Clinical laboratories in this era of digital health are rapidly migrating towards the use of specialized, electronic laboratory equipment, instruments and analytical tools. Poised to benefit in this regard are innovative microplate systems such as multimode readers capable of measuring photometry, fluorometry, luminometry, time-resolved fluorometry with flexibility and high performance. The miniaturization trend sweeping through the electronics industry is resulting in the development of microplates in small factors. This is an important development given the increasing miniaturization of biological assays. Benefits of performing automated assays at the nanoliter scale include process efficiency, increase in productivity, reduced labor and resource utilization, higher speed and quality of data acquisition. All of these benefits are vital in the pharmaceutical industry which is today feeling all of the challenges of declining productivity and diminishing returns on investment. Microplates with microwells are therefore growing in demand for use in miniaturized assay development and screening in modern drug discovery.

Few of the noteworthy technology innovations in this market include development of microplates that use less reagents; growing success of DropArray microplates over traditional microplate due to features such as unique wall-less design that eliminates capillary action, and reduced need for expensive dispensing and aspiration instruments; development of microplates with several thousand wells per microplate; launch of colored microplates for different optical readouts; and innovations in microplate coatings i.e. tissue culture treated plates & coatings to prevent non-specific binding. Few of the other major trends in the market include popularity of Polystyrene & Polypropylene based microplates; and rise in enzyme-linked immunosorbent assays (ELISA) and immunoassay tests against the backdrop of growing need for infectious disease testing and biotherapeutics drug discovery. The United States and Europe represent largest markets worldwide with a combined share of 71.9%. China ranks as the fastest growing market with a 6.6% CAGR over the analysis period supported by the globalization of the country's life sciences sector. Supportive policies legislated by the Chinese governments have helped increase the number of life science companies operating in the market, while also enabling these companies to deliver critical innovations in medical products. Illustrative of the evolving domestic life sciences sector and also the opening up of opportunities for exporting Chinese-made pharmaceuticals is the two Chinese-produced vaccines prequalified by WHO in the year 2018. Asia-Pacific excluding China follows next with a 5.3% CAGR led by India, and other Southeast Asian countries.
» End-Use (Biotechnology & Pharmaceutical, Hospital & Diagnostic Laboratories, Research Institutes, Academic Institutes) » Product (Microplate Reader, Pipetting Systems and Dispensers, Washers, Other Products)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

  • A: 
    ACTIVE CLIENT
  • B: 
    INACTIVE CLIENT
  • C: 
    ACTIVE PANELIST
  • D: 
    INACTIVE PANELIST
  • E: 
    OPT-INS
  
REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com